Addition of sFlt-1 for second and third trimester pre-eclampsia management rounds out portfolio WALTHAM, Mass. – June 10, 2020 – PerkinElmer, Inc. , a global leader committed to innovating for a healthier world, announced today the addition of the DELFIA® Xpress sFlt-1 kit to its CE-IVD Read more
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) is paving the way for large-scale, next-generation sequencing-based (NGS) COVID-19 testing. Today, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the Illumina COVIDSeq™ Test, a high-throughput, sequencing-based, in vitro diagnostic (IVD) workflow enabling the detection of SARS-CoV-2. The end-to-end workflow extends the options... Read more
Increased capacity required to meet growing demand for Raman imaging microscopes Ulm, Germany June 10th, 2020 WITec GmbH, the technology leader in correlative Raman microscopy, is expanding its headquarters building in Ulm. The new addition will offer more space for production and quality assurance, laboratories for development and customer demonstrations or sample measurements, larger conference... Read more
MINNEAPOLIS, June 11, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH) today announced that Exosome Diagnostics, a Bio-Techne brand, has established a new partnership with ZERO – The End of Prostate Cancer, the leading national nonprofit organization in the fight against prostate cancer. ZERO advances research, improves the lives of men and families, and inspires action for patients,... Read more
Chicago, Illinois – June 9, 2020 – To help empower clinicians and patients in their fight against breast cancer, GE Healthcare today announced the Food and Drug Administration’s 510(k) clearance of Pristina Serena Bright™*, the healthcare industry’s first contrast-enhanced mammography solution for https://www.genewsroom.com/press-releases/ge-healthcare-receives-fda-clearance-industry%E2%80%99s-first-contrast-enhanced-mammography Read more
New diagnostic test for MSI in solid tumors can inform physicians on immuno-oncology therapies and can guide treatment decisions for patients with Lynch-associated cancers Leiden, Netherlands and Madison, WI USA. (June 9, 2020) Promega Corporation today announced CE marking for the OncoMate™ MSI Dx Analysis System(OncoMate™ MSI) as a new in vitro diagnostic (IVD) medical device in Europe.... Read more
Researchers use scanning electron microscopy (SEM) to characterize a lightweight, flexible material with high performance shielding capabilities From wearable fitness trackers, such as smartwatches, to wearable healthcare devices, such as ECG and blood pressure monitors, there is a rising demand for increasingly advanced wearable devices. Devices such as these are packed with highly integrated circuits,... Read more
Agreement calls for identifying IDH gene mutations using Oncomine Precision Assay and the Ion Torrent Genexus System, a new turnkey, next-generation sequencing solution Read more
World-leading precision in mass imaging together with optical observationsRelease of the iMScope QT Imaging Mass Microscope Read more